Plant ID: NPO5823
Plant Latin Name: Helichrysum auriceps
Taxonomy Genus: Helichrysum
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
1442641
Plant-of-the-World-Online:
n.a.
TSHR; | |
ALPL; TDP1; HSD17B10; | |
GAA; | |
CA2; CA12; CA9; CA7; CA5A; CA3; CA14; CA5B; CA4; CA1; CA6; | |
PPARA; PPARD; | |
TLR2; | |
NFKB1; | |
SLC5A1; SLC5A2; SLC5A4; | |
HTT; FABP3; FABP5; FABP2; FABP4; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | P05186 | CHEMBL5979 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
SLC superfamily of solute carriers | SLC5A1 | Sodium/glucose cotransporter 1 | P13866 | CHEMBL4979 |
SLC superfamily of solute carriers | SLC5A2 | Sodium/glucose cotransporter 2 | P31639 | CHEMBL3884 |
SLC superfamily of solute carriers | SLC5A4 | Low affinity sodium-glucose cotransporter | Q9NY91 | CHEMBL1770047 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 7.645E-10 | 1.110E-06 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, PPARA, PPARD |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 5.070E-08 | 5.810E-05 | FABP2, FABP3, FABP4, FABP5 |
MF | GO:0005215; transporter activity | GO:0005412; glucose:sodium symporter activity | 6.067E-08 | 6.605E-05 | SLC5A1, SLC5A2, SLC5A4 |
BP | Unclassified; | GO:0015758; glucose transport | 6.399E-07 | 5.806E-04 | PPARD, SLC5A1, SLC5A2, SLC5A4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.349E-29 | 2.937E-25 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | Unclassified; | GO:0035428; hexose transmembrane transport | 4.596E-06 | 2.944E-03 | SLC5A1, SLC5A2, SLC5A4 |
BP | GO:0051179; localization | GO:1904659; glucose transmembrane transport | 4.596E-06 | 2.944E-03 | SLC5A1, SLC5A2, SLC5A4 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 6.523E-06 | 3.689E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 7.393E-23 | 8.049E-19 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.502E-21 | 1.362E-17 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 3.252E-05 | 1.507E-02 | CA1, CA2 |
MF | GO:0005488; binding | GO:0036041; long-chain fatty acid binding | 1.187E-04 | 4.535E-02 | FABP3, PPARD |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 8.327E-29 | 7.245E-27 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA4, CA7, CA6, CA9, CA14 |
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 6.024E-10 | 2.621E-08 | FABP2, FABP3, FABP4, FABP5, PPARA, PPARD |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.466E-04 | 4.252E-03 | CA2, SLC5A1, CYP3A4 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 5.040E-04 | 1.096E-02 | CA2, CA4 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 2.930E-03 | 3.354E-02 | PPARA, NFKB1, TSHR |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 2.874E-03 | 3.354E-02 | NFKB1, TLR2 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 3.084E-03 | 3.354E-02 | NFKB1, PPARD |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 2.978E-03 | 3.354E-02 | FABP4, TSHR |
09160 Human Diseases | 09162 Immune diseases | hsa05321 | Inflammatory bowel disease (IBD) | 3.990E-03 | 3.857E-02 | NFKB1, TLR2 |
09160 Human Diseases | 09167 Infectious diseases | hsa05140 | Leishmaniasis | 5.006E-03 | 3.959E-02 | NFKB1, TLR2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | SLC5A4; SLC5A1; SLC5A2; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
NA: NA | Edema | NA | CA2; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
A00-B99: Certain infectious and parasitic diseases | Anthelmintic | B89 | ALPL; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 1/2 diabetes | E08-E13 | SLC5A4; |
C00-D49: Neoplasms | Colon cancer | C50 | ALPL; |
K00-K95: Diseases of the digestive system | Liver disease | K70-K77 | SLC5A2; |
Q00-Q99: Congenital malformations, deformations and chromosomal abnormalities | Genetic disease | Q00-Q99 | ALPL; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 1 diabetes | E10 | SLC5A2; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; SLC5A4; SLC5A1; SLC5A2; |